Northern Trust Corp Pardes Biosciences, Inc. Transaction History

Northern Trust Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$1.4 - $1.95 $300,735 - $418,881	-214,811 Reduced 87.23%	31,442 $56,000
Q1 2023 May 15, 2023	SELL	$1.21 - $2.22 $252 - $463	-209 Reduced 0.08%	246,253 $325,000
Q4 2022 Feb 13, 2023	SELL	$0.85 - $1.69 $10,729 - $21,332	-12,623 Reduced 4.87%	246,462 $416,000
Q3 2022 Nov 14, 2022	BUY	$2.14 - $3.7 $55,883 - $96,621	26,114 Added 11.21%	259,085 $479,000
Q2 2022 Aug 12, 2022	BUY	$2.84 - $8.57 $519,365 - $1.57 Million	182,875 Added 365.05%	232,971 $715,000
Q1 2022 May 13, 2022	BUY	$5.64 - $15.64 $282,541 - $783,501	50,096 New	50,096 $362,000

5.23M

Ticker PRDS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,320,900
Description
Pardes Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics to improve the lives of patients suffering from life-threatening disease. Its lead candidate is the PBI-0451 that is in clinical development stage to treat and prevent severe acute respiratory syndrome ...

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

Stay updated on Northern Trust Corp with notifications on news.